文献速递眼底病与葡萄膜炎

提升糖尿病视网膜病变诊断与分级:一项关于人工智能辅助决策及成本分析的回顾性研究

Enhancing diabetic retinopathy diagnosis and grading: a retrospective study on AI-assisted decision making and cost analysis.
PubMed 文献 · Br J Ophthalmol · 2026-05-20

该回顾性研究分析224张视网膜图像,由21名中国眼科医生和基层医生分别在无AI辅助和有AI辅助下依据彩色眼底照片和超广角眼底图像诊断并分级糖尿病视网膜病变。AI辅助显著提高诊断准确率,广义估计方程显示AI辅助的增量成本为4.79单位、准确率提升0.35单位。

要点

  • AI辅助显著提高彩色眼底照片糖尿病视网膜病变诊断准确率。
  • AI辅助显著提高超广角眼底图像糖尿病视网膜病变诊断准确率。
  • 广义估计方程显示AI辅助增量成本4.79单位、准确率提升0.35单位。

核心结论

  • AI辅助在提高糖尿病视网膜病变诊断和分级准确率方面显示出潜力。
  • 尽管存在相关成本,AI使眼科医生能够实现更优诊断,有助于更早发现和治疗糖尿病视网膜病变。

研究设计与样本

  • 回顾性研究,共分析224张视网膜图像。
  • 由21名中国眼科医生和基层医生参与,先独立依据彩色眼底照片和超广角眼底图像诊断并分级糖尿病视网膜病变,间隔1周后在AI辅助下重复该任务。

主要发现

  • 彩色眼底照片:基层医生诊断准确率从79.90%升至85.68%,眼科住院医师从81.19%升至88.69%,眼科主治医师从81.41%升至88.05%。
  • 超广角眼底图像:眼科住院医师诊断准确率从83.62%升至89.66%,眼科主治医师从81.31%升至88.98%。
  • 广义估计方程分析显示,AI辅助的增量成本为4.79单位,准确率提升为0.35单位。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: Diabetic retinopathy (DR) is a major ocular complication of diabetes mellitus. While artificial intelligence (AI)-based DR screening tools have gained widespread adoption, most research focuses on comparing AI performance with human, with limited attention to AI's role as assistants. This study evaluates the impact of AI-assisted decision-making on DR diagnosis and grading based on colour fundus photographs (CFP) and ultra-widefield fundus (UWF) images. METHODS: A total of 224 retinal images were analysed by 21 ophthalmologists and primary care physicians (PCPs) in China. Participants independently diagnosed and graded DR based on CFP and UWF images. After a 1-week interval, they repeated the task with AI assistance. Diagnosis accuracy was compared with a gold standard before and after AI assistance. Incremental costs and accuracy improvements were assessed using generalized estimating equations (GEE) models. RESULTS: AI assistance significantly improved DR diagnosis accuracy for both CFP and UWF images. For CFP, accuracy increased from 79.90% to 85.68% for PCPs, 81.19% to 88.69% for ophthalmic residents and 81.41% to 88.05% for ophthalmic attendings. Similar improvements were observed for UWF, with accuracy rising from 83.62% to 89.66% for residents and from 81.31% to 88.98% for attendings. GEE analysis revealed an incremental cost of 4.79 units and an accuracy improvement of 0.35 units with AI assistance. CONCLUSION: AI assistance shows potential in improving the accuracy of DR diagnosis and grading. Despite the associated costs, AI enables ophthalmologists to achieve superior diagnosis, facilitating earlier DR detection and treatment.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Xu X, Zhang J, Song X, et al. Enhancing diabetic retinopathy diagnosis and grading: a retrospective study on AI-assisted decision making and cost analysis. Br J Ophthalmol. 2026. PMID: 41115744. doi:10.1136/bjo-2025-327442

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。